Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
Reaction products of diazotised 2-amin-6-nitrophenol-4-sulphonic Acid and 2-Amino-4-nitrophenol-6-sulfonic Acid, coupled with a mixture of 6-Amino-4-hydroxy-2-naphthalenesulfonic Acid and Acetylated 6-Amino-4-hydroxy-2-naphthalenesulfonic Acid, subsequently metallized with Chromium (III) Basic Sulfate and Acetic Acid, and at the end diazotised and coupled with p-Cresol, sodium salts
EC number: 405-750-6 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Acute Toxicity: oral
Administrative data
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 989
- Report date:
- 1989
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 401 (Acute Oral Toxicity)
- Version / remarks:
- February 24, 1987
- Deviations:
- yes
- Remarks:
- dose volume of 20 ml/ bw
- GLP compliance:
- yes
- Test type:
- fixed dose procedure
- Limit test:
- yes
Test material
- Reference substance name:
- -
- EC Number:
- 405-750-6
- EC Name:
- -
- Molecular formula:
- Not applicable for UVCB substance
- IUPAC Name:
- diiron(3+) dihydrogen tris(7-[2-(2-hydroxy-5-methylphenyl)diazen-1-yl]-2-[2-(3-nitro-2-oxido-5-sulfophenyl)diazen-1-yl]-3-sulfonaphthalen-1-olate) 7-acetamido-2-[2-(3-nitro-2-oxido-5-sulfophenyl)diazen-1-yl]-3-sulfonaphthalen-1-olate
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Wistar
- Remarks:
- albino
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
-Source: Charles River Wiga, Sulzfeld, West-Germany
-Age at start of treatment: approx. 7 weeks
-Body weight at start of treatment: males 230-260 g, females: 162-185 g
-Identification: earmark
-Acclimation period: at least 5 days under laboratory conditions
-Housing: groups of five per sex in polycarbonate cages containing purified sawdust as bedding material (Woody Clean supplied by Broekman Institute, Someren, The Netherlands).
-Diet: standard pelleted laboratory animal diet (RMH-B from Hope Farms, Woerden, The Netherlands), ad libitum
-Water: tap-water, ad libitum
ENVIRONMENTAL CONDITIONS
-Temperature: 21 ± 3 °C
-Humidity: 30-70 %
-Air changes: 7.5-15 per hr with air-conditioned
-Photoperiod: 12 hrs artificial fluorescent light / 12 hrs dark per day
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- water
- Remarks:
- prepared by reverse osmosis
- Details on oral exposure:
- TREATMENT
-Fasting: feed was withheld overnight prior to dosing until approximately 3-4 hours after administration of the test substance.
-Frequency: once, on day 1
-Dose volume: 20 ml/kg bw. - Doses:
- 5000 mg/kg bw
- No. of animals per sex per dose:
- -5 males at 5000 mg/kg
-5 females at 5000 mg/kg - Control animals:
- no
- Details on study design:
- TEST SUBSTANCE PREPARATION
The formulations were prepared immediately prior to dosing. The test substance was weighed into a glass flask on an analytical balance and the vehicle (w/w) was added. Homogeneity was obtained by a homogeniser.
OBSERVATIONS
-Mortality / Viability: at periodic intervals on the day of dosing (day 1) and twice daily thereafter for at least 14 days
-Body Weights: test days 1 (pre-administration), 8 and 15
-Symptoms: at periodic intervals on the day 1, once daily thereafter. All signs of reaction to treatment were recorded with particular attention paid to changes in the skin, fur, eyes and mucous membranes, as well as to behaviour pattern, tremors, convulsion, salivations, diarrhoea, lethargy, sleep and coma.
NECROPSY FINDINGS
All animals were necropsied and descriptions of all macroscopic abnormalities were recorded. All animals surviving to the end of the observation period were sacrificed by carbon dioxide asphyxiation and subjected to necropsy.
Results and discussion
Effect levels
- Key result
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- > 5 000 mg/kg bw
- Based on:
- test mat.
- Mortality:
- No mortality occurred during the study period.
- Clinical signs:
- other: Lethargy was noted among all the animals on days 1 and/or 2. All animals appeared blue in colour (having blue discoloured skin) and all males had diarrhoea or blue discoloured diarrhoea on day 1. No other clinical signs of toxicity or behavioural changes
- Gross pathology:
- Macroscopic examination of all animals at termination revealed the stomach wall and testes of one male to be greyish in colour.
Two females were noted to have greyish coloured stomach walls and one of these females also had a greyish discolouration of the subcutis and most other organs, enlarged spleen and a black surface to the kidneys.
Applicant's summary and conclusion
- Interpretation of results:
- other: Not classified according to CLP Regulation (EC 1272/2008)
- Conclusions:
- The acute oral LD50 of the substance in rats (both sexes) was estimated to exceed 5000 mg/kg bw.
- Executive summary:
The oral acute toxicity of the substance was evaluated with a limit test to albino rat Wistar, according to the OECD Guideline 401 (1987). Two groups, each of 5 males and 5 females, were treated with a 5000 mg/kg bw single dose of the substance suspended in an aqueous solution and administered by oral gavage. Symptoms and mortality after administration were recorded during the observation period of 14 days. Thereafter all animals were submitted to necropsy and macroscopic examination. No mortality occurred during the study period.
The oral LD50 value of the substance in rats was estimated to exceed 5000 mg/kg bw.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.